Literature DB >> 12532103

Receptor internalization is required for eotaxin-induced responses in human eosinophils.

Nives Zimmermann1, Marc E Rothenberg.   

Abstract

BACKGROUND: CC chemokine receptor 3 (CCR3) is a major chemokine receptor involved in regulating eosinophil trafficking, and therefore the elucidation of ligand-induced CCR3 events has important implications in understanding the biologic and pathologic properties of eosinophils. After ligand binding to CCR3, cellular signals include stimulatory (ie, calcium mobilization, actin polymerization, shape change, and chemotaxis) and inhibitory (ie, desensitization of the receptor) events. We have previously demonstrated that CCR3 undergoes rapid and prolonged ligand-induced internalization.
OBJECTIVE: Here we explore the role of internalization in downstream cellular processes, including shape change, actin polymerization, calcium mobilization, and desensitization.
METHODS: Peripheral blood-derived human eosinophils were pretreated with 2 mechanistically distinct inhibitors of internalization, sucrose and phenylarsine oxide, and functional responses were monitored.
RESULTS: We first demonstrate that ligand-induced internalization is required for chemokine-induced eosinophil shape change. To define which signaling components upstream of eosinophil shape change required internalization, we next studied the role of internalization in calcium mobilization and actin polymerization. Sucrose and phenylarsine oxide pretreatment inhibited actin polymerization, implicating receptor internalization in this early response. In contrast, calcium mobilization was not inhibited by blockade of internalization. Finally, we were interested in testing the role of internalization in receptor desensitization. We first demonstrated that preincubation with eotaxin induced a dose-dependent desensitization in eotaxin-induced eosinophil transepithelial migration. However, this phenomenon was not inhibited by blockade of internalization.
CONCLUSION: These results establish that CCR3 internalization is critically involved in select eosinophil functional responses (ie, cellular shape change and actin polymerization) but not desensitization and calcium mobilization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532103     DOI: 10.1067/mai.2003.3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Eosinophil granules function extracellularly as receptor-mediated secretory organelles.

Authors:  Josiane S Neves; Sandra A C Perez; Lisa A Spencer; Rossana C N Melo; Lauren Reynolds; Ionita Ghiran; Salahaddin Mahmudi-Azer; Solomon O Odemuyiwa; Ann M Dvorak; Redwan Moqbel; Peter F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

Review 2.  Chemokine receptor internalization and intracellular trafficking.

Authors:  Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-05       Impact factor: 7.638

3.  Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells.

Authors:  Christine Lingblom; Henrik Bergquist; Marianne Johnsson; Patrik Sundström; Marianne Quiding-Järbrink; Mogens Bove; Christine Wennerås
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

4.  Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation.

Authors:  Ping Ling; Karen Ngo; Steven Nguyen; Robin L Thurmond; James P Edwards; Lars Karlsson; Wai-Ping Fung-Leung
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

5.  Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion.

Authors:  Lisa A Spencer; Rossana C N Melo; Sandra A C Perez; Staci P Bafford; Ann M Dvorak; Peter F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

6.  Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.

Authors:  Miguel L Stein; Joyce M Villanueva; Bridget K Buckmeier; Yoshiyuki Yamada; Alexandra H Filipovich; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2008-04-14       Impact factor: 10.793

Review 7.  Eosinophils in the pathogenesis of allergic airways disease.

Authors:  S G Trivedi; C M Lloyd
Journal:  Cell Mol Life Sci       Date:  2007-05       Impact factor: 9.261

8.  Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness.

Authors:  Milica Grozdanovic; Kimberly G Laffey; Hazem Abdelkarim; Ben Hitchinson; Anantha Harijith; Hyung-Geon Moon; Gye Young Park; Lee K Rousslang; Joanne C Masterson; Glenn T Furuta; Nadya I Tarasova; Vadim Gaponenko; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2018-05-17       Impact factor: 10.793

9.  Aiolos regulates eosinophil migration into tissues.

Authors:  Jennifer M Felton; Carine Bouffi; Justin T Schwartz; Kaila L Schollaert; Astha Malik; Sushmitha Vallabh; Benjamin Wronowski; Adam Z Magier; Li Merlin; Artem Barski; Matthew T Weirauch; Patricia C Fulkerson; Marc E Rothenberg
Journal:  Mucosal Immunol       Date:  2021-08-02       Impact factor: 8.701

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.